戻る Agendas
Session 0704 Development of Biosimilars in China: Interpretation of Biosimilar Guidance, Opportunities and Challenges - II
Session Chair(s)
Joe Zhang
Co-founder and CEO
BJ Bioscience Inc., China
Speaker(s)
Weidong Jiang
Henlius, China
Chief Strategy Officer and Senior Vice President
Science Based BiosimilarRegulatory Pathway
Irene Deng
Sanofi, China
Head of Regulatory Affairs, China
Cindy Xu
Henlius, China